Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Dupilumab users have a higher risk of developing alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional liposuction for cell therapy.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The study suggests that hypothyroidism may cause alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Regulatory T cells are essential for normal and improved wound healing in mice.

People with vitiligo may have a lower risk of heart disease.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.